# RayCare 3.1

> Active: United States. Medical device record on deviCERTS, compiled from public registries.

- Canonical page: <https://devicerts.com/devices/raycare-3-1-muj>
- Manufacturer: [RaySearch Laboratories AB (PUBL)](https://devicerts.com/manufacturers/raysearch-laboratories-ab-publ) (Sweden)
- Device class: Class II (US FDA)
- FDA product code: MUJ

## Overview

*AI-generated summary, 2026-09-19. Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data is the record.*

The RayCare 3.1 is a Radiation Therapy Treatment Planning System (Class II), designed to assist in the planning and delivery of radiation therapy for oncology patients. It provides computational tools for dose calculation, treatment optimization, and contouring to support precise radiation treatment strategies in radiology settings.

This software-based device is intended for use in clinical environments by authorized personnel, requiring no sterility as it is non-invasive and non-reusable. It operates independently of MRI safety concerns and is supplied as a standalone system with no physical consumables. The device holds FDA 510(k) clearance (K200487) under the Radiology advisory committee, with regulatory compliance under 21 CFR 892.5050. Installation and use adhere to manufacturer-provided guidelines for radiation therapy workflows.

## Registrations and authorizations

- **510(k)** · FDA 510(k) · United States · K200487 · decision 2020-06-10 · decision SESE · status: Active

## Recalls

- Z-0206-2024 · Class II · ongoing · initiated 2023-09-12: An issue was found in RayCare 5B, 6A, including service packs, where values will not be visible for documents in a read-only state when opened outside the Documents workspace when using document fields configured with single- or multi-selectable values.
- Z-2464-2023 · Class II · ongoing · initiated 2023-07-17: An issue was found in Software RayCare 5A, 5B, 6A, including service packs, where an allergy warning against medication substance (drug ingredient) will not be displayed as expected under certain circumstances
- Z-2138-2021 · Class II · terminated · initiated 2021-06-08: Initial delivery positions will be set incorrectly when having setup beam(s) at the localization point.
- Z-1281-2021 · Class II · ongoing · initiated 2021-03-03: Patient related messages created in RayCare 3B, RayCare 4A will be lost when upgrading from RayCare 2 to RayCare 3B or later
- Z-2899-2020 · Class II · ongoing · initiated 2020-07-29: When performing offline image review in RayCare 2C, RayCare 3A and RayCare 3B an offline image review task will guide you to the image viewer with the treatment image related to the fraction and the planning image selected. When starting the task, an error message might be displayed stating: Review files not available.

## Identifiers

- 510(k) Number: K200487 [FDA 510(k)]
- FDA product code: MUJ [FDA 510(k)]

## Classification

- Device class: Class II [FDA 510(k)]
- Regulation: 21 CFR Part 892.5050 [FDA 510(k)]
- Advisory committee: Radiology [FDA 510(k)]
- FDA decision: SESE [FDA 510(k)]

## Source and citation

- Cite as: RayCare 3.1, RaySearch Laboratories AB (PUBL). deviCERTS medical device catalogue. https://devicerts.com/devices/raycare-3-1-muj (data as of 2026-11-20).
- Data sources: [FDA 510(k)](https://open.fda.gov/apis/device/510k/), [FDA recalls](https://open.fda.gov/apis/device/recall/)
- Registry records last synced: 2026-10-22
- Statuses computed as of: 2026-11-20
- JSON: <https://devicerts.com/devices/raycare-3-1-muj.json>
- Licence: [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/). The deviCERTS layout and text are licensed under CC BY 4.0. Registry data remain under their source terms: U.S. FDA data (openFDA, AccessGUDID) are U.S. public domain; EUDAMED data are subject to the European Commission reuse terms.
- Attribution: DevicErts, https://devicerts.com/devices/raycare-3-1-muj
- Compiled by deviCERTS (devicerts.com) from public medical device registries (EUDAMED, European Commission; U.S. FDA via openFDA; AccessGUDID, U.S. National Library of Medicine). deviCERTS is not an official register and gives no regulatory advice: the record in the registry itself prevails.
